Array Biopharma Inc (NASDAQ:ARRY)

15.89
Delayed Data
As of May 25
 +0.25 / +1.60%
Today’s Change
7.15
Today|||52-Week Range
18.78
+24.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-85.3M9.4M-92.8M-116.8M
 
 
 
 
 
Depreciation4.5M3.7M1.5M2.1M
 
 
 
 
 
Total Other Cash Flow5.1M-25.9M13.7M21.0M
 
 
 
 
 
Funds From Operations-75.7M-12.8M-77.7M-93.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.0M-7.0M-7.6M-54.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-71.7M-5.8M-70.1M-39.4M
 
 
 
 
 
 
InvestingIncrease In Investments-95.6M-202.9M-139.2M-387.6M
 
 
 
 
 
Decrease In Investments100.7M143.6M208.3M333.0M
 
 
 
 
 
Capital Expenditures-2.6M-2.5M-3.2M-3.5M
 
 
 
 
 
Fixed Asset Disposal--3.8M0.000.00
 
 
Net Cash Flow Investing2.5M-58.0M66.0M-58.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00--10.0M
 
 
Long Term Borrowings-86.0K0.000.0014.8M
 
 
 
Long Term Debt Reduction0.000.000.00-14.6M
 
 
Net Proceeds Stock Sale77.1M50.9M4.9M156.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.0046.0K0.00
 
 
Other Uses - Financing0.000.00--0.00--
Net Cash Flow - Financing77.1M50.9M5.0M166.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash7.9M-12.9M907.0K69.3M